Reuters logo
BRIEF-Cadila Healthcare Says ‍Zydus Gets Final Nod From U.S. FDA For Candesartan Cilexetil And Hydrochlorothiazide Tablets​
November 29, 2017 / 5:08 AM / 15 days ago

BRIEF-Cadila Healthcare Says ‍Zydus Gets Final Nod From U.S. FDA For Candesartan Cilexetil And Hydrochlorothiazide Tablets​

Nov 29 (Reuters) - Cadila Healthcare Ltd:

* SAYS ‍ZYDUS GETS FINAL APPROVAL FROM U.S. FDA FOR CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE TABLETS

* DRUG IS INTENDED TO TREAT HYPERTENSION; TO BE MADE AT GROUP'S FORMULATIONS FACILITY AT AHMEDABAD​ Source text - bit.ly/2zO1W9J Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below